Stock Analysis on Net
Stock Analysis on Net

CVS Health Corp. (NYSE:CVS)

This company has been moved to the archive! The financial data has not been updated since May 1, 2025.

Analysis of Short-term (Operating) Activity Ratios

Microsoft Excel

Short-term Activity Ratios (Summary)

CVS Health Corp., short-term (operating) activity ratios

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Turnover Ratios
Inventory turnover 17.75 16.83 14.05 13.52 11.88
Receivables turnover 10.16 10.12 11.79 11.91 12.32
Payables turnover 20.22 20.36 18.07 19.14 19.72
Working capital turnover — — — — —
Average No. Days
Average inventory processing period 21 22 26 27 31
Add: Average receivable collection period 36 36 31 31 30
Operating cycle 57 58 57 58 61
Less: Average payables payment period 18 18 20 19 19
Cash conversion cycle 39 40 37 39 42

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


The analysis of operational activity ratios reveals a period of shifting efficiency drivers, characterized by significant improvements in inventory management that are partially offset by a slowing trend in receivables collection.

Inventory Management Efficiency
A consistent upward trend is observed in inventory turnover, which rose from 11.88 in 2020 to 17.75 by 2024. This improvement is further evidenced by the average inventory processing period, which decreased steadily from 31 days to 21 days over the same period, indicating a higher velocity of stock movement and improved logistics efficiency.
Receivables and Collection Performance
Conversely, the receivables turnover exhibits a downward trajectory, declining from 12.32 in 2020 to 10.16 in 2024. This decline is reflected in the average receivable collection period, which lengthened from 30 days to 36 days, suggesting a slower conversion of credit sales into cash and a potential shift in credit terms or collection efficacy.
Payables and Obligation Cycles
Payables turnover has remained relatively stable, fluctuating between a low of 18.07 in 2022 and a high of 20.36 in 2023. The average payables payment period showed minimal variance, maintaining a range between 18 and 20 days, which indicates a consistent approach to managing obligations to suppliers.
Operating and Cash Conversion Cycles
The operating cycle has remained stable, ending at 57 days in 2024 compared to 61 days in 2020. The cash conversion cycle followed a similar pattern of stability, moving from 42 days in 2020 to 39 days in 2024. This suggests that the operational gains realized through faster inventory turnover have effectively neutralized the negative impact of the increased collection period for receivables.

Overall, the organization has successfully optimized its inventory throughput, though this efficiency is balanced by a slight deterioration in the speed of cash inflows from receivables. The net result is a stabilized cash conversion cycle, ensuring a consistent flow of working capital.

AI Ask an analyst for more


Turnover Ratios


Average No. Days


Inventory Turnover

CVS Health Corp., inventory turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Cost of revenues 321,408 303,345 268,173 240,063 219,660
Inventories 18,107 18,025 19,090 17,760 18,496
Short-term Activity Ratio
Inventory turnover1 17.75 16.83 14.05 13.52 11.88
Benchmarks
Inventory Turnover, Competitors2
Abbott Laboratories 3.02 2.74 3.10 3.59 —
Intuitive Surgical Inc. 1.83 1.96 2.27 2.98 —
Medtronic PLC 2.15 2.03 2.20 2.43 —
Inventory Turnover, Sector
Health Care Equipment & Services 32.90 30.37 30.70 31.85 —
Inventory Turnover, Industry
Health Care 7.56 7.36 7.85 7.90 —

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Inventory turnover = Cost of revenues ÷ Inventories
= 321,408 ÷ 18,107 = 17.75

2 Click competitor name to see calculations.


The analysis of operating activity reveals a consistent improvement in inventory management efficiency over the five-year period ending December 31, 2024. A strong correlation is observed between the steady rise in the cost of revenues and a corresponding increase in the inventory turnover ratio, while total inventory levels remained relatively stable.

Cost of Revenues Growth
A sustained upward trajectory is evident in the cost of revenues, which increased from US$ 219,660 million in 2020 to US$ 321,408 million in 2024. This represents a significant expansion in the scale of operations and the volume of goods processed through the supply chain.
Inventory Level Stability
Inventory balances demonstrated minimal volatility throughout the period, fluctuating within a narrow range between US$ 17,760 million and US$ 19,090 million. Despite the substantial growth in operational volume, total inventory holdings did not increase proportionally, indicating a disciplined approach to stock management.
Inventory Turnover Performance
The inventory turnover ratio improved monotonically from 11.88 in 2020 to 17.75 in 2024. This trend signifies that the company is cycling through its inventory more rapidly, which typically suggests enhanced liquidity and a decreased risk of inventory obsolescence.

The divergence between the rising cost of revenues and the stagnant inventory levels indicates that the increase in turnover is driven by operational efficiency. This pattern suggests that the organization has successfully optimized its supply chain to support higher sales volumes without requiring a commensurate increase in working capital investment in inventory.

AI Ask an analyst for more


Receivables Turnover

CVS Health Corp., receivables turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Revenues from customers 370,656 356,623 321,629 290,912 267,908
Accounts receivable, net 36,469 35,227 27,276 24,431 21,742
Short-term Activity Ratio
Receivables turnover1 10.16 10.12 11.79 11.91 12.32
Benchmarks
Receivables Turnover, Competitors2
Abbott Laboratories 6.06 6.11 7.02 6.64 —
Elevance Health Inc. 18.00 18.08 18.81 20.66 —
Intuitive Surgical Inc. 6.82 6.30 6.60 7.30 —
Medtronic PLC 5.28 5.21 5.71 5.51 —
UnitedHealth Group Inc. 17.66 17.27 18.22 20.07 —
Receivables Turnover, Sector
Health Care Equipment & Services 13.93 13.74 14.33 14.76 —
Receivables Turnover, Industry
Health Care 7.97 7.66 8.22 8.00 —

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Receivables turnover = Revenues from customers ÷ Accounts receivable, net
= 370,656 ÷ 36,469 = 10.16

2 Click competitor name to see calculations.


An analysis of the five-year period ending December 31, 2024, reveals a consistent increase in top-line revenue accompanied by a corresponding expansion in net accounts receivable, resulting in a general decline in receivables turnover efficiency.

Revenue Growth Trends
Revenues from customers exhibited steady year-over-year growth, rising from 267,908 million USD in 2020 to 370,656 million USD in 2024. This trajectory indicates a sustained expansion of the company's sales volume over the analyzed period.
Accounts Receivable Expansion
Net accounts receivable increased from 21,742 million USD in 2020 to 36,469 million USD in 2024. A notable acceleration in the growth of outstanding receivables occurred between 2022 and 2023, when the balance rose from 27,276 million USD to 35,227 million USD, suggesting a higher volume of credit extended to customers or a slowdown in payment collections.
Receivables Turnover Performance
The receivables turnover ratio experienced a overall downward trend, decreasing from 12.32 in 2020 to 10.16 in 2024. The most significant contraction occurred between 2022 and 2023, falling from 11.79 to 10.12. This pattern indicates that the company is taking longer to collect its average receivables balance relative to its revenue generation. A marginal stabilization was observed in 2024, with the ratio slightly increasing to 10.16, suggesting that the pace of receivable growth has aligned more closely with revenue growth in the final year of the period.

AI Ask an analyst for more


Payables Turnover

CVS Health Corp., payables turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Cost of revenues 321,408 303,345 268,173 240,063 219,660
Accounts payable 15,892 14,897 14,838 12,544 11,138
Short-term Activity Ratio
Payables turnover1 20.22 20.36 18.07 19.14 19.72
Benchmarks
Payables Turnover, Competitors2
Abbott Laboratories 4.46 4.19 4.15 4.21 —
Elevance Health Inc. 8.10 7.72 7.47 7.59 —
Intuitive Surgical Inc. 14.05 12.69 13.78 14.45 —
Medtronic PLC 4.65 4.03 4.46 4.98 —
UnitedHealth Group Inc. 7.72 7.47 7.26 7.63 —
Payables Turnover, Sector
Health Care Equipment & Services 7.48 7.14 6.94 7.18 —
Payables Turnover, Industry
Health Care 6.10 5.97 5.79 5.84 —

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Payables turnover = Cost of revenues ÷ Accounts payable
= 321,408 ÷ 15,892 = 20.22

2 Click competitor name to see calculations.


Operational scale has expanded consistently from 2020 through 2024, as evidenced by the steady growth in both cost of revenues and accounts payable. The overall trend indicates an increase in procurement volume and corresponding obligations to suppliers.

Cost of Revenues Growth
An uninterrupted annual increase is observed, with expenditures rising from 219,660 million in 2020 to 321,408 million in 2024. This upward trajectory reflects a significant expansion in the cost of goods and services required to support business operations.
Accounts Payable Trends
Payables grew steadily over the analyzed period, moving from 11,138 million in 2020 to 15,892 million in 2024. The growth in payables largely aligns with the increase in cost of revenues, suggesting a proportional scaling of short-term liabilities.
Payables Turnover Analysis
The payables turnover ratio exhibited a fluctuating pattern. A gradual decline was noted between 2020 and 2022, falling from 19.72 to 18.07, which indicates a slight lengthening of the payment cycle to suppliers. This trend reversed sharply in 2023, with the ratio increasing to 20.36, followed by a period of stabilization at 20.22 in 2024. The high turnover ratios throughout the period suggest a very rapid cycle of purchasing and payment, with the recovery in 2023 and 2024 indicating a return to more aggressive payment frequencies.

AI Ask an analyst for more


Working Capital Turnover

CVS Health Corp., working capital turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Current assets 68,645 67,858 65,682 60,008 56,369
Less: Current liabilities 84,609 79,189 69,736 67,807 62,017
Working capital (15,964) (11,331) (4,054) (7,799) (5,648)
 
Revenues from customers 370,656 356,623 321,629 290,912 267,908
Short-term Activity Ratio
Working capital turnover1 — — — — —
Benchmarks
Working Capital Turnover, Competitors2
Abbott Laboratories 4.42 4.54 4.48 3.87 —
Elevance Health Inc. 7.85 7.83 8.37 7.23 —
Intuitive Surgical Inc. 1.56 1.14 1.29 1.22 —
Medtronic PLC 2.90 2.47 2.97 2.15 —
UnitedHealth Group Inc. — — — — —
Working Capital Turnover, Sector
Health Care Equipment & Services 23.57 23.27 25.59 16.28 —
Working Capital Turnover, Industry
Health Care 12.35 10.99 11.30 8.57 —

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Working capital turnover = Revenues from customers ÷ Working capital
= 370,656 ÷ -15,964 = —

2 Click competitor name to see calculations.


An analysis of short-term operating activity reveals a consistent growth in revenue paired with a persistent and expanding negative working capital position from 2020 through 2024.

Revenue Growth Trends
Total revenues from customers demonstrate a steady upward trajectory, increasing from US$ 267,908 million in 2020 to US$ 370,656 million by the end of 2024. This represents a continuous expansion of the top line over the five-year period.
Working Capital Dynamics
Working capital has remained negative throughout the analyzed period. Following a moderate increase in the deficit in 2021, a temporary reduction occurred in 2022, where the deficit narrowed to US$ -4,054 million. However, the deficit widened sharply in 2023 to US$ -11,331 million and continued to expand to US$ -15,964 million in 2024.
Working Capital Turnover Interpretation
The negative values for working capital result in a negative turnover ratio, indicating an operational model where current liabilities exceed current assets. The divergence between steadily increasing revenues and a deepening working capital deficit suggests an intensified reliance on short-term obligations to fund operational growth. This pattern often reflects a strategy of leveraging supplier credit or maintaining high inventory turnover to finance expanding business activities without increasing current assets proportionally.

AI Ask an analyst for more


Average Inventory Processing Period

CVS Health Corp., average inventory processing period calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data
Inventory turnover 17.75 16.83 14.05 13.52 11.88
Short-term Activity Ratio (no. days)
Average inventory processing period1 21 22 26 27 31
Benchmarks (no. days)
Average Inventory Processing Period, Competitors2
Abbott Laboratories 121 133 118 102 —
Intuitive Surgical Inc. 200 186 161 122 —
Medtronic PLC 170 180 166 150 —
Average Inventory Processing Period, Sector
Health Care Equipment & Services 11 12 12 11 —
Average Inventory Processing Period, Industry
Health Care 48 50 46 46 —

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ 17.75 = 21

2 Click competitor name to see calculations.


An analysis of the operational activity ratios from 2020 to 2024 reveals a consistent improvement in inventory management efficiency. The indicators demonstrate a steady progression toward optimized asset utilization and enhanced supply chain velocity.

Inventory Turnover
A consistent upward trend is observed in the inventory turnover ratio, which increased from 11.88 in 2020 to 17.75 by the end of 2024. This growth reflects an increased frequency of inventory replacement and suggests a heightened efficiency in converting stock into revenue.
Average Inventory Processing Period
Conversely, the average inventory processing period exhibits a continuous decline, decreasing from 31 days in 2020 to 21 days in 2024. This reduction of 10 days over the five-year period indicates that goods are moving through the distribution cycle more rapidly, which typically correlates with lower holding costs and a reduced risk of inventory obsolescence.
Operational Correlation
The inverse relationship between the rising turnover ratio and the falling processing period underscores a systematic optimization of the inventory cycle. The synchronization of these metrics points to an improved ability to align procurement levels with actual market demand.

AI Ask an analyst for more


Average Receivable Collection Period

CVS Health Corp., average receivable collection period calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data
Receivables turnover 10.16 10.12 11.79 11.91 12.32
Short-term Activity Ratio (no. days)
Average receivable collection period1 36 36 31 31 30
Benchmarks (no. days)
Average Receivable Collection Period, Competitors2
Abbott Laboratories 60 60 52 55 —
Elevance Health Inc. 20 20 19 18 —
Intuitive Surgical Inc. 54 58 55 50 —
Medtronic PLC 69 70 64 66 —
UnitedHealth Group Inc. 21 21 20 18 —
Average Receivable Collection Period, Sector
Health Care Equipment & Services 26 27 25 25 —
Average Receivable Collection Period, Industry
Health Care 46 48 44 46 —

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ 10.16 = 36

2 Click competitor name to see calculations.


Analysis of the company's operating activity ratios from 2020 to 2024 indicates a gradual decline in the efficiency of receivable collections, characterized by a decreasing turnover rate and a corresponding increase in the average collection period.

Receivables Turnover
A consistent downward trajectory was observed from 2020 through 2023, with the turnover ratio declining from 12.32 to 10.12. This trend suggests a reduction in the frequency with which the company converts its accounts receivable into cash. The ratio showed marginal stabilization in 2024, closing at 10.16, which indicates a plateauing of the turnover rate.
Average Receivable Collection Period
The time required to collect outstanding receivables increased from 30 days in 2020 to 36 days in 2023 and 2024. The collection period remained stable at 31 days during the 2021 and 2022 fiscal years before experiencing a notable increase of five days in 2023. This extension has persisted into the 2024 period.
Operational Synthesis
The inverse relationship between the turnover ratio and the collection period highlights a slowing of the cash conversion cycle. The increase in the collection window from 30 to 36 days represents a 20% increase in the average time capital remains tied up in receivables, potentially impacting short-term liquidity and the availability of operational cash flow.

AI Ask an analyst for more


Operating Cycle

CVS Health Corp., operating cycle calculation, comparison to benchmarks

No. days

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data
Average inventory processing period 21 22 26 27 31
Average receivable collection period 36 36 31 31 30
Short-term Activity Ratio
Operating cycle1 57 58 57 58 61
Benchmarks
Operating Cycle, Competitors2
Abbott Laboratories 181 193 170 157 —
Intuitive Surgical Inc. 254 244 216 172 —
Medtronic PLC 239 250 230 216 —
Operating Cycle, Sector
Health Care Equipment & Services 37 39 37 36 —
Operating Cycle, Industry
Health Care 94 98 90 92 —

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= 21 + 36 = 57

2 Click competitor name to see calculations.


Analysis of the operating cycle indicates a general trend toward stability with a slight overall reduction in the time required to convert inventory and receivables into cash. While the total duration has remained relatively constant between 57 and 61 days over the five-year period, there are contrasting movements within the individual components of the cycle.

Average Inventory Processing Period
A consistent downward trend is observed in the inventory processing period, which decreased from 31 days in 2020 to 21 days in 2024. This steady decline suggests improved inventory management efficiency and a faster turnover of goods, reducing the amount of capital tied up in stock.
Average Receivable Collection Period
The receivable collection period remained stable at approximately 30 to 31 days between 2020 and 2022, followed by an increase to 36 days in 2023 and 2024. This upward shift indicates a deceleration in the collection of payments, suggesting a potential increase in the credit terms granted to customers or a slowdown in payer reimbursement processes.
Overall Operating Cycle
The operating cycle exhibits a slight contraction from 61 days in 2020 to 57 days in 2024. The efficiency gains achieved in the inventory processing phase effectively offset the lengthening of the receivable collection period. Consequently, the net time required to complete the operating cycle has remained resilient, fluctuating only marginally over the analyzed period.

AI Ask an analyst for more


Average Payables Payment Period

CVS Health Corp., average payables payment period calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data
Payables turnover 20.22 20.36 18.07 19.14 19.72
Short-term Activity Ratio (no. days)
Average payables payment period1 18 18 20 19 19
Benchmarks (no. days)
Average Payables Payment Period, Competitors2
Abbott Laboratories 82 87 88 87 —
Elevance Health Inc. 45 47 49 48 —
Intuitive Surgical Inc. 26 29 26 25 —
Medtronic PLC 78 91 82 73 —
UnitedHealth Group Inc. 47 49 50 48 —
Average Payables Payment Period, Sector
Health Care Equipment & Services 49 51 53 51 —
Average Payables Payment Period, Industry
Health Care 60 61 63 63 —

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ 20.22 = 18

2 Click competitor name to see calculations.


The analysis of operating activity ratios reveals a high degree of stability in the management of accounts payable from 2020 through 2024, characterized by a rapid and consistent settlement cycle.

Payables Turnover
A slight contraction in the payables turnover ratio was observed between 2020 and 2022, with the ratio declining from 19.72 to 18.07. This trend reversed in 2023, when the ratio climbed to 20.36, remaining relatively stable at 20.22 by the end of 2024. The overall trajectory indicates that the frequency of payable settlements remained high, with a slight increase in turnover efficiency in the most recent two fiscal years.
Average Payables Payment Period
The duration required to settle obligations with suppliers showed minimal variance over the five-year period. The payment period remained constant at 19 days during 2020 and 2021, reached a marginal peak of 20 days in 2022, and subsequently decreased to 18 days in both 2023 and 2024. This consistency suggests a rigid adherence to payment terms and a disciplined approach to managing short-term liabilities.

The narrow fluctuations in the payment period indicate that the company maintains a highly efficient cash-to-supplier pipeline. The transition from a 20-day period in 2022 to an 18-day period in 2024 suggests a slight acceleration in the settlement of payables, contributing to a more rapid turnover of operating liabilities.

AI Ask an analyst for more


Cash Conversion Cycle

CVS Health Corp., cash conversion cycle calculation, comparison to benchmarks

No. days

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data
Average inventory processing period 21 22 26 27 31
Average receivable collection period 36 36 31 31 30
Average payables payment period 18 18 20 19 19
Short-term Activity Ratio
Cash conversion cycle1 39 40 37 39 42
Benchmarks
Cash Conversion Cycle, Competitors2
Abbott Laboratories 99 106 82 70 —
Intuitive Surgical Inc. 228 215 190 147 —
Medtronic PLC 161 159 148 143 —
Cash Conversion Cycle, Sector
Health Care Equipment & Services -12 -12 -16 -15 —
Cash Conversion Cycle, Industry
Health Care 34 37 27 29 —

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= 21 + 36 – 18 = 39

2 Click competitor name to see calculations.


The overall cash conversion cycle has demonstrated a general downward trajectory from 2020 to 2024, moving from 42 days to 39 days. While the cycle reached a minimum of 37 days in 2022, it experienced a slight uptick in 2023 before stabilizing. This indicates a modest improvement in the efficiency of converting resource inputs into cash flows over the five-year period.

Inventory Processing Period
A consistent and significant downward trend is observed in the average inventory processing period, which decreased from 31 days in 2020 to 21 days in 2024. This steady reduction suggests enhanced operational efficiency in inventory management and a faster turnover of goods.
Receivable Collection Period
The average receivable collection period remained stable at approximately 30 to 31 days between 2020 and 2022, but increased to 36 days by 2023 and 2024. This upward trend indicates a deceleration in the collection of payments, which has acted as a counterweight to the gains achieved in inventory processing.
Payables Payment Period
The average payables payment period has remained relatively stagnant, fluctuating narrowly between 18 and 20 days over the analyzed period. The absence of significant expansion in this metric suggests a maintenance of consistent payment terms with suppliers, providing little to no contribution toward shortening the overall cash conversion cycle.
Cash Conversion Cycle Synthesis
The net movement of the cash conversion cycle is the result of opposing operational trends. The 10-day improvement in inventory processing was largely offset by a 6-day increase in the receivable collection period. As a result, the overall liquidity cycle has remained relatively stable since 2021, fluctuating within a narrow range of 37 to 40 days.

AI Ask an analyst for more